SIRT1 controls enteroendocrine progenitor cell proliferation in high-fat diet-fed mice
Compounded meds may reflect disparities in ingredients and quality, but they are typically safe when sourced from FDA-regulated 503A facilities, which Hims partners with
Want more on GLP-1 agonists
Conditions under active investigation include prediabetes, heart failure with preserved ejection fraction, obstructive sleep apnoea, knee osteoarthritis, polycystic ovarian syndrome, and inflammatory bowel disease
Our goal is to help each patient improve their overall health, mobility, and quality of life through personalized and effective weight management strategies
GLP-1 drugs have been approved for the treatment of diabetes and obesity, meaning that the FDA has determined that for people with these disorders, the benefits of taking the drug outweigh the potential risks